Your browser doesn't support javascript.
Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination.
Jo, Dong-Ho; Minn, Dohsik; Lim, Jaegyun; Lee, Ki-Deok; Kang, Yu-Min; Choe, Kang-Won; Kim, Kwang-Nam.
  • Jo DH; Division of Infectious Disease, Department of Internal Medicine, Myongji Hospital, Goyang 10475, Korea.
  • Minn D; Seegene Medical Foundation, Seoul 05548, Korea.
  • Lim J; Department of Laboratory Medicine, Myongji Hospital, Goyang 10475, Korea.
  • Lee KD; Division of Infectious Disease, Department of Internal Medicine, Myongji Hospital, Goyang 10475, Korea.
  • Kang YM; Division of Infectious Disease, Department of Internal Medicine, Myongji Hospital, Goyang 10475, Korea.
  • Choe KW; Division of Infectious Disease, Department of Internal Medicine, Myongji Hospital, Goyang 10475, Korea.
  • Kim KN; Department of Pediatrics, Myongji Hospital, Goyang 10475, Korea.
Vaccines (Basel) ; 9(10)2021 Oct 08.
Article in English | MEDLINE | ID: covidwho-1463853
ABSTRACT
The efficacy and safety of the BNT162b2 vaccine are known, but antibodies are expected to decrease over time after vaccination. We collected blood samples from 104 fully vaccinated health care workers at 3 and 5 weeks after first vaccination and 4 months after second vaccination. Antibody titers and neutralizing antibodies were measured. In our study, both antibody titers and neutralizing antibodies increased significantly at 5 weeks after first vaccination but decreased rapidly at 4 months after second vaccination. Additionally, the results showed a significant decrease regardless of gender or age. Further studies are needed to help determine the interval of SARS-CoV-2 vaccinations.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2021 Document Type: Article